KH007 Archives | Koneksa Health

Koneksa Press Release KH007 Topline Results thumbnail image

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

By Koneksa HealthNews

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL — September 1, 2026 —Koneksa Health...

September 1, 2026

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

By Koneksa HealthNews

Completion of data collection enables full analysis, with topline results expected in June 2026 New York, NY — 23 April 2026 — Koneksa, a measurement-science partner for clinical development,...

April 23, 2026

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

By Koneksa HealthNews

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...

January 13, 2025

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

By Koneksa HealthArticle

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...

January 13, 2025

KH007

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa